Treat-to-Target Eczema — SCE Dermatology MCQ

Correct answer: C — Setting a specific treatment goal (e.g., EASI <7, DLQI <5) and adjusting therapy systematically until that target is achieved and maintained — proactive approach

The 'treat-to-target' approach in atopic eczema involves: (1) Setting a specific measurable treatment goal (e.g., EASI <7 or IGA 0/1 for 'clear/almost clear' skin); (2) Systematically escalating therapy through the treatment ladder until the target is achieved; (3) Maintaining therapy to sustain the target; (4) Regular objective assessment with validated tools. This approach, borrowed from rheumatology and cardiology, aims to achieve the best possible disease control rather than accepting suboptimal outcomes. It aligns with the proactive treatment philosophy — maintaining clear/almost clear skin prevents the cycle of flares and reduces cumulative disease burden, itch, and quality of life impact.

Reference: BAD 2020 AD Guidelines; HOME Initiative